Date published: 2026-3-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

BTBD14B Activators

BTB/POZ domain-containing protein 14B (BTBD14B) is a protein that in humans is encoded by the BTBD14B gene. The protein is characterized by the presence of a BTB/POZ domain, a protein-protein interaction motif that allows it to participate in diverse cellular functions.BTBD14B, like other proteins containing the BTB/POZ domain, is thought to be involved in protein-protein interactions and may play a role in the regulation of cellular processes such as transcription, cytoskeleton dynamics, ion channel assembly and gating, and protein degradation.

However, other proteins in the BTB/POZ domain-containing family have been implicated in various biological processes and diseases, including cancer and neurodegenerative disorders, suggesting that BTBD14B could also play important roles in human health and disease.For instance, some BTB/POZ domain-containing proteins are known to act as transcriptional regulators, influencing gene expression by interacting with other proteins to modulate the activity of transcription factors. Continuing research into BTBD14B and other BTB/POZ domain-containing proteins will likely provide valuable insights into their roles in cellular function and their implications for human health and disease.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132 is a proteasome inhibitor which may affect protein degradation pathways potentially linked with BTBD14B.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Epoxomicin is another proteasome inhibitor that can impact protein turnover and possibly influence BTBD14B functions.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Lactacystin is a specific inhibitor of the proteasome, affecting protein degradation pathways that could be relevant to BTBD14B.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, potentially affecting protein folding and stability, possibly influencing BTBD14B.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin disrupts calcium homeostasis in the endoplasmic reticulum, potentially impacting cellular processes involving BTBD14B.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits protein synthesis, potentially altering the cellular context in which BTBD14B functions.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Geldanamycin, another HSP90 inhibitor, could influence protein folding and degradation pathways involving BTBD14B.